Tenet Healthcare Overview
Tenet Healthcare Target Price
Where could THC trade next? Consensus target price: $280.
Get informed when a big investor buys or sells
+ FollowShare Price
$268.45
Average Target Price
$280.88
4.6% upside
4.6% upside17 analysts in the last 4 months
High: $308 | Low: $231
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-10-16 | Guggenheim | $307 | 14.4% upside |  |
| 2026-09-22 | BMO Capital | $265 |  1.3% downside | |
| 2026-08-14 | Raymond James | $285 | 6.2% upside | |
| 2026-08-10 | Mizuho Securities | $290 | 8% upside | |
| 2026-08-03 | Wells FargoStephen Baxter | $281 | 4.7% upside | |
| 2026-07-28 | Goldman SachsScott Fidel | $305 | 13.6% upside | |
| 2026-07-28 | Truist FinancialDavid MacDonald | $290 | 8% upside | |
| 2026-07-28 | Robert W. BairdMichael Ha | $280 | 4.3% upside | |
| 2026-07-27 | Stephens | $285 | 6.2% upside | |
| 2026-07-27 | RBC Capital | $283 | 5.4% upside | |
| 2026-07-27 | Raymond JamesSarah James | $270 | 0.6% upside | |
| 2026-07-27 | Morgan Stanley | $274 | 2.1% upside | |
| 2026-07-27 | Piper Sandler | $308 | 14.7% upside | |
| 2026-07-27 | UBS | $308 | 14.7% upside | |
| 2026-07-24 | Barclays | $271 | 0.9% upside | |
| 2026-07-20 | Guggenheim | $242 | 9.9% downside | |
| 2026-07-13 | Wells FargoStephen Baxter | $231 | 14% downside | |
| 2026-05-05 | BarclaysAndrew Mok | $238 | 11.3% downside | |
| 2026-05-05 | Robert W. Baird | $210 | 21.8% downside | |
| 2026-05-04 | StephensScott Fidel | $260 | 3.1% downside | |
| 2026-05-01 | Morgan Stanley | $254 | 5.4% downside | |
| 2026-03-12 | GuggenheimJason Cassorla | $283 | 5.4% upside | |
| 2026-02-17 | Truist Financial | $270 | 0.6% upside | |
| 2026-02-16 | Wells FargoStephen Baxter | $265 | 1.3% downside | |
| 2026-02-13 | Guggenheim | $271 | 0.9% upside | |
| 2026-02-13 | BarclaysAndrew Mok | $257 | 4.3% downside | |
| 2026-02-12 | UBS | $288 | 7.3% upside | |
| 2026-02-12 | Morgan Stanley | $260 | 3.1% downside | |
| 2026-02-12 | RBC Capital | $277 | 3.2% upside | |
| 2026-02-12 | KeyBancMatthew Gillmor | $250 | 6.9% downside | |
| 2026-02-03 | RBC CapitalBen Hendrix | $253 | 5.8% downside | |
| 2026-01-07 | Wells Fargo | $229 | 14.7% downside | |
| 2025-12-18 | Morgan StanleyCraig Hettenbach | $247 | 8% downside | |
| 2025-12-02 | Guggenheim | $257 | 4.3% downside | |
| 2025-11-21 | BarclaysAndrew Mok | $240 | 10.6% downside | |
| 2025-11-03 | Truist Financial | $240 | 10.6% downside | |
| 2025-10-30 | RBC Capital | $252 | 6.1% downside | |
| 2025-10-29 | Raymond JamesSarah James | $245 | 8.7% downside | |
| 2025-10-29 | UBS | $260 | 3.1% downside | |
| 2025-10-29 | Morgan Stanley | $232 | 13.6% downside | |
| 2025-10-29 | Guggenheim | $238 | 11.3% downside | |
| 2025-10-17 | Mizuho SecuritiesAnn Hynes | $225 | 16.2% downside | |
| 2025-10-14 | Truist FinancialDavid MacDonald | $225 | 16.2% downside | |
| 2025-10-14 | Goldman SachsScott Fidel | $224 | 16.6% downside | |
| 2025-10-08 | KeyBancMatthew Gillmor | $225 | 16.2% downside | |
| 2025-10-07 | Wells FargoStephen Baxter | $238 | 11.3% downside | |
| 2025-09-18 | Barclays | $229 | 14.7% downside | |
| 2025-07-16 | Truist FinancialDavid MacDonald | $205 | 23.6% downside | |
| 2025-03-26 | Morgan Stanley | $165 | 38.5% downside | |
| 2025-01-07 | KeyBancMatthew Gillmor | $185 | 31.1% downside | |